Parkinson Hastalığının "Risk Altında" Bir Nüfusu Ana hatlarıyla Anlatmak: Bir Vaka Kontrol Çalışmasının Kanıtı.
Outlining a Population "at Risk" of Parkinson's Disease: Evidence from a Case-Control Study.
DOI: 10.1155/2016/9646057PMID: 27651975
Outlining a Population "at Risk" of Parkinson's Disease: Evidence from a Case-Control Study.
DOI: 10.1155/2016/9646057PMID: 27651975
Plasma exosome concentration may correlate with cognitive impairment in Parkinson's disease.
DOI: 10.1016/j.dadm.2016.08.002PMID: 27722197
Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation.
DOI: 10.1073/pnas.1604645113PMID: 27573854
Advances in dopamine receptor agonists for the treatment of Parkinson's disease.
DOI: 10.1080/14656566.2016.1219337PMID: 27561098
Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes.
DOI: 10.1002/hbm.23360PMID: 27571419
Interaction between subclinical doses of the Parkinson's disease associated gene, α-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats.
DOI: 10.1016/j.bbr.2016.08.056PMID: 27585560
Parkinsonian monkeys with prior levodopa-induced dyskinesias followed by fetal dopamine precursor grafts do not display graft-induced dyskinesias.
DOI: 10.1002/cne.24081PMID: 27418401
A Case of Painless Legs and Moving Toes Syndrome in Parkinson's Disease Responsive to Dopaminergic Therapy.
DOI: 10.1155/2016/6829410PMID: 27648321
Drosophila Mutant Model of Parkinson's Disease Revealed an Unexpected Olfactory Performance: Morphofunctional Evidences.
DOI: 10.1155/2016/3508073PMID: 27648340
Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness.
DOI: 10.1016/j.bbrc.2016.08.153PMID: 27581196
Effects of a balance-based exergaming intervention using the Kinect sensor on posture stability in individuals with Parkinson's disease: a single-blinded randomized controlled trial.
DOI: 10.1186/s12984-016-0185-yPMID: 27568011
Corrigendum to "Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes" [Parkinsonism Relat. Disord. 21(3) (2015) 231-235].
DOI: 10.1016/j.parkreldis.2016.08.012PMID: 27575745
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.